FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 128 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,063,000 | – | 502,177 | +8369516.7% | 0.03% | – |
| Q1 2020 | $0 | -100.0% | 6 | -100.0% | 0.00% | -100.0% |
| Q2 2018 | $1,265,000 | -7.9% | 80,000 | 0.0% | 0.02% | -13.0% |
| Q1 2018 | $1,374,000 | -21.7% | 80,000 | 0.0% | 0.02% | -23.3% |
| Q4 2017 | $1,754,000 | -14.3% | 80,000 | +60.0% | 0.03% | -16.7% |
| Q3 2017 | $2,046,000 | +15.1% | 50,000 | -15.3% | 0.04% | +9.1% |
| Q2 2017 | $1,777,000 | +53.6% | 59,000 | +84.4% | 0.03% | +50.0% |
| Q1 2017 | $1,157,000 | -27.8% | 32,000 | 0.0% | 0.02% | -40.5% |
| Q4 2016 | $1,603,000 | +27.2% | 32,000 | +33.3% | 0.04% | +23.3% |
| Q3 2016 | $1,260,000 | +12.8% | 24,000 | -11.1% | 0.03% | +3.4% |
| Q2 2016 | $1,117,000 | -23.2% | 27,000 | -25.0% | 0.03% | -19.4% |
| Q1 2016 | $1,455,000 | -68.5% | 36,000 | -67.7% | 0.04% | -71.0% |
| Q4 2015 | $4,619,000 | +208.3% | 111,300 | +14.4% | 0.12% | +235.1% |
| Q3 2015 | $1,498,000 | – | 97,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,781,346 | $25,867,000 | 3.38% |
| GREAT POINT PARTNERS LLC | 2,398,409 | $22,305,000 | 2.82% |
| Sofinnova Investments, Inc. | 315,344 | $2,933,000 | 0.36% |
| EcoR1 Capital, LLC | 326,775 | $3,039,000 | 0.30% |
| Rock Springs Capital Management LP | 505,000 | $4,697,000 | 0.22% |
| Hilltop Holdings Inc. | 36,146 | $336,000 | 0.08% |
| OXFORD ASSET MANAGEMENT LLP | 285,237 | $2,653,000 | 0.07% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 191,237 | $1,779,000 | 0.06% |
| FOX RUN MANAGEMENT, L.L.C. | 12,132 | $113,000 | 0.06% |
| Virtus ETF Advisers LLC | 31,427 | $292,000 | 0.05% |